Roger J. Waltzman - 07 Aug 2023 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Medical Officer
Signature
/s/ Nir Sassi, Attorney-in-Fact for Roger J. Waltzman
Issuer symbol
INDP
Transactions as of
07 Aug 2023
Transactions value $
$0
Form type
4
Filing time
07 Aug 2023, 17:25:41 UTC
Previous filing
17 Feb 2023
Next filing
23 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (Right to Buy) Award $0 +90K $0.00 90K 07 Aug 2023 Common Stock 90K $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on August 7, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on August 7, 2026.